By Pierre Fabre…
To get in touch with Pierre Fabre Médicament: Supercritical Fluids Division, simply fill out the form below.
Subscribe to Supplier
Pierre Fabre Supercritical Fluids displays breakthrough technologies at CPhI/ICSE Worldwide
Gaillac, France: – Highly innovative process experts Pierre Fabre Medicament Supercritical Fluids Division will exhibit its breakthrough technologies at the landmark ICSE outsourcing event in Madrid, part of the huge CPhI Worldwide 2015 expo.
The Supercritical Fluids department will be represented at the Pierre Fabre Group CDMO Stand at Booth 3J20 in Hall 3 at Madrid’s IFEMA as part of the ICSE show.
The Supercritical Fluids display at ICSE is adapted to feature the company’s pre-formulation services for API, including the highly innovative Formulplex that improves solubility of API as well as enhancing bioavailability along with Formuldisp stable solid dispersion for improved excipient functionality and Formulcoat taste-masking.
Late last year, Supercritical Fluids posted details of a new process leading to significant energy savings on production of the western world’s most popular painkiller, ibuprofen.
The ICSE team will include Bernard Freiss, Head of Supercritical Fluids department, and Hubert Lochard, Supercritical Fluids Project Manager.
“We are regular exhibitors at the event, which connects the pharmaceutical community with outsourcing solution providers. CPhI Worldwide / ICSE is the world’s largest exhibition for global pharmaceutical ingredients, fine chemicals, excipients and intermediates – all core areas for Supercritical Fluids division,” commented Bernard Freiss.
“Regarding our Supercritical Fluids Department, people can meet us on the Pierre Fabre CDMO stand to see how our services can meet their need in term of development of poorly soluble API, reformulation of already marketed APIs and more besides,” said Mr. Freiss.
The team will be reaching out to R&D managers, business development and formulation experts for whom process efficiency and effectiveness and cGMP compliance are critical issues.
“We’ll also be showing ways for clients to transfer their whole process into Supercritical Fluids state of the art facilities to optimize production and carry out demanding cGMP manufacture in batches,” he added.
About Pierre Fabre Supercritical Fluids
Pierre Fabre’s Supercritical Fluids division has developed specialized expertise in supercritical fluids technology for pharmaceutical applications, in particular in Drug Delivery Systems (DDS).
PFM SuperCritical Fluids is responsible for the development and application of Pierre Fabre Medicament’s Formulplex® process that uses Supercritical CO2 as a reactive medium to increase the solubility of pharmaceutical active ingredients.
The division is part of Pierre Fabre Médicament, one of France’s largest independent pharmaceutical laboratories, focusing on ethical drugs, health products and dermocosmetic products.
Originally based in Castres in the French Midi-Pyrenees Departement, Pierre Fabre has a presence in more than 130 countries worldwide and has a combined workforce of more than 10,000 people of whom more than 3.500 work outside France.
About ICSE/CPhI 2015
CPhI Worldwide / ICSE is one of the biggest pharmaceutical industry events in the world.
Now in its 26th year, the 2015 event is a three-day event opening October 13 at IFEMA, Feria de Madrid. Last year’s even in Paris attracted almost 36,500 delegates and 2,500 exhibitor companies from more than 150 countries worldwide.
The CPhl Worldwide show is being held alongside two other zoned exhibitions; P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.
The Pre-Connect Conference on October 12 brings together senior representatives and key stakeholders from all segments of the industry for a series of market-led educational modules on the latest trends and topics with networking and partnering opportunities.
The CPhI Pharma Awards, presented on the first evening of the conference, honor innovative companies and leaders. The previous three categories (formulation, process development and packaging) have now been expanded to eight awards, now additionally honoring best innovations in biologic drug development and manufacturing, supply chain & logistic management, manufacturing technology, APIs and excipients, as well as CEO of the Year.
The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live.
More information at: http://www.cphi.com/europe/home